SCHEMBL17434736

SCHEMBL17434736

COCCOc1cccc(Nc2ccc(C(N)=O)c(NCc3ccccc3)n2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 6/20 0.54
RPS6KB1 P23443 4/20 0.54
AURKB Q96GD4 3/20 0.51
SIRT2 Q8IXJ6 9/20 0.50
JAK2 O60674 2/20 0.48
JAK1 P23458 2/20 0.48
JAK3 P52333 2/20 0.48
TYK2 P29597 1/20 0.48
IRAK4 Q9NWZ3 1/20 0.48
MAPT P10636 2/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
POLB P06746 1/20 0.46
KMT2A Q03164 1/20 0.46
SYK P43405 1/20 0.44
MAPK1 P28482 1/20 0.44
RECQL P46063 1/20 0.44
BLM P54132 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2694589 0.84 JAK3 (0.70) AURKARPS6KB1AURKBSIRT2JAK2
SCHEMBL2729346 0.82 ROCK1 (0.47) AURKARPS6KB1SIRT2SYK
SCHEMBL2716084 0.81 SIRT2 (0.52) AURKARPS6KB1AURKBSIRT2JAK2
SCHEMBL2696155 0.74 JAK3 (0.73) AURKARPS6KB1SIRT2JAK2JAK1
SCHEMBL2481086 0.74 JAK3 (0.76) SIRT2JAK2JAK1JAK3TYK2
SCHEMBL17434737 0.74 MAPT (0.44) MAPTMEN1ALDH1A1POLBKMT2A
SCHEMBL17088518 0.73 JAK3 (0.57) AURKARPS6KB1JAK2JAK1JAK3
SCHEMBL21167727 0.72 ROCK1 (0.42) AURKARPS6KB1AURKBMAPTMEN1
SCHEMBL17150843 0.71 SYK (0.51) AURKARPS6KB1AURKBMAPTSYK
SCHEMBL21167726 0.71 SYK (0.40) AURKARPS6KB1AURKBSYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2975027-A1 NICOTINAMIDES AS JAK KINASE MODULATORS Portola Pharmaceuticals, Inc. (US) 2016-01-20 EP disclosed